BioXcel Therapeutics, Inc. (BTAI) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $164.0K | -92.3% |
| 2024 | $2.14M | +70.1% |
| 2023 | $1.26M | +6200.0% |
| 2022 | $20.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $164.0K | -92.3% |
| 2024 | $2.14M | +70.1% |
| 2023 | $1.26M | +6200.0% |
| 2022 | $20.0K | — |